Prevalencia de Hidradenitis Suppurativa, estudiada en USA.

Prevalence of HS in General Population Analyzed

JAMA Dermatol; ePub 2017 May 10; Garg, et al

May 17, 2017

Hidradenitis suppurativa (HS) is an uncommon disease in the US that disproportionately affects female patients, young adults, and African American and biracial patients, according to a recent study. This retrospective analysis included a demographically heterogeneous population-based sample of >48 million unique patients across all US census regions. A total of 47,690 patients with HS were identified using electronic health record data. Researchers found:

• Of total patients with HS (26.2% men and 73.8% women), the overall HS prevalence in the US population sample was 0.10%, or 98 per 100,000 persons.
• The adjusted prevalence in women was 137 per 100,000, more than twice that of men (58 per 100,000).
• The prevalence of HS was highest among patients aged 30 to 39 years (172 per 100,000) compared with all other age groups (range, 15-150 per 100,000).
• Adjusted HS prevalence among African American (296 per 100,000) and biracial (218 per 100,000) patients were more than 3-fold and 2-fold greater, respectively, than that among white patients (95 per 100,000).

Citation:

Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. [Published online ahead of print May 10, 2017]. JAMA Dermatol. doi:10.1001/jamadermatol.2017.0201.